News

Press Releases

October 26, 2021
Exo Therapeutics Appoints Dorothy Lou Bailey as Senior Vice President, Corporate Development and Strategy

October 5, 2021
Exo Therapeutics Raises $78 Million Series B Financing

March 30, 2021
Exo Therapeutics Appoints Nagesh Mahanthappa to Board of Directors and Charles W. Roberts to Scientific Advisory Board

December 16, 2020
Exo Therapeutics Launches with $25 Million Series A Financing to Unlock Intractable Drug Targets with Exosites

July 23, 2020
A startup emerging from David Liu’s lab intends to commercialize a small-molecule enzyme inhibitor discovery platform to generate more potent drugs with higher specificity.

We are a diverse group of scientists, researchers, and business leaders with the mission to develop a novel approach to medicines discovery with exosites.
Careers